Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
Published 4 weeks ago
Description
In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pharma regulatory roundup covers two significant FDA approvals, and Pharmaceutical Executive speaks with Raj Indupuri, CEO of eClinical Solutions, on making the ROI case for smarter clinical trials in an era of exploding trial data complexity.